Datagov Opendata Platform

The Health Insurance Administration has selected evidence-based medical indicators to be made public in order to enhance the quality of medical care for patients with myocardial infarction, and serve as a reference for relevant disease treatment or health care quality; the public indicators are categorized into three major types according to the treatment period and quality aspects, including inpatient process assessment, post-discharge continuous drug treatment assessment, and outcome assessment. This includes the ratio of inpatients with acute myocardial infarction (AMI) receiving LDL cholesterol testing during hospitalization, the medication ratio for AMI patients during hospitalization, and at three, six, and nine months post-discharge, the rate of emergency room revisit within three days after discharge for the same primary diagnosis or related conditions, and the unplanned readmission rate within fourteen days after discharge for the same primary diagnosis or related conditions.